Parkin, an E3 ubiquitin ligase encoded by <i>PARK2</i>, plays a key role in both hereditary and sporadic Parkinson's disease (PD), yet there are no therapies currently available that can target this important pathway. This evidence concerns the gene PRKN and Parkinson disease.